BD is one of the largest global medical technology companies, advancing health by improving medical discovery, diagnostics, and care delivery. With a presence in nearly every country, BD develops innovative technologies and solutions that empower scientists, clinicians, and healthcare providers to deliver better outcomes with greater precision and efficiency.
Opentrons and BD are collaborating to automate single-cell multiomics workflows on the Opentrons Flex. A cornerstone of the collaboration is an automation-compatible module for the BD Rhapsody™ platform, enabling seamless cell capture on the Opentrons Flex. By integrating the technologies, researchers will gain access to an automated, end-to-end workflow that covers cell capture and NGS library preparation for single-cell multiomics studies.
